Article
The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
Diabetes - 1 Dec 2003
Caramori Maria Luiza, Canani Luis Henrique, Costa Luciana A, Gross Jorge Luiz
Abstract excerpt
The peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism has been associated with a decreased risk of type 2 diabetes and a lower albumin excretion rate (AER) in patients with established diabetes. We performed a case-control study aiming to evaluate the association between the Pro12Ala polymorphism and diabetic nephropathy. Genomic DNA was obtained from 104 type 2 diabetic...
Topics
- Aged
- Alanine
- Case-Control Studies
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Female
- Gene Frequency
- Genetic Predisposition to Disease
- Heterozygote
- Humans
